Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy

Elisa Oricchio(Swiss Cancer Center Léman), Hans‐Guido Wendel(Kettering University)
The Journal of Experimental Medicine
June 9, 2014
Cited by 33


Related Papers